SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-15-000060
Filing Date
2015-05-11
Accepted
2015-05-11 08:34:00
Documents
3
Period of Report
2015-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_Q12015EARNINGSRELEASE ligand-8xkq12015earningsre.htm 8-K 19698
2 EXHIBIT 99.1_Q12015EARNINGSRELEASE q12015earningsrelease.htm EX-99.1 152537
3 ligandlogoa03a01a01a01.jpg GRAPHIC 36525
  Complete submission text file 0000886163-15-000060.txt   223860
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 15849000
SIC: 2834 Pharmaceutical Preparations